BEHANDLUNG VON LUNGENFIBROSE

Patent europeic · EP4138798 · En vigur

Inscripziun en il register

Numer da publicaziun
EP4138798
Numer da la dumonda
EP21722978
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
20-04-2021
Publitgà
01-03-2023
Concedì
09-07-2025
La protecziun finescha il pli tard
19-04-2041
Proxima taxa annuala scadenta
30-04-2026
Classas IPC
A61K 31/07 (2006.01)
A61P 11/00 (2006.01)
Prioritad
GB 202005727 20.04.2020
GB 202104041 23.03.2021
Dumonda PCT
PCT/GB2021/050948 20.04.2021
Publicaziun PCT
WO2021/214451 28.10.2021
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 21-05-2026

    Midada

    Published in Swissreg on 21.05.2026

  2. 09-07-2025

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 09.07.2025

Partidas

Possessur

Regenall Limited

19 Harley Street, London W1G 9QJ, GB

Inventur

NOORDEEN, Mohamed Hamza

London Greater London W1G 9QJ, GB

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.